Research summary ·
Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This review looked at optic neuritis linked to anti-CRMP5 antibodies. The abstract calls this a rare cause of optic neuritis. So far, it was known mainly from case reports and small case series. The team gathered every published case of this problem. In all, the review took in 32 people from these reports.
What they found
People had a median age of 67, and most had both eyes affected. Many had very poor sight, while eye pain was rare. Most had a cancer, often small-cell lung cancer. Swelling of the optic disc and inflammation inside the eye were common. MRI scans were often normal, but spinal fluid nearly always showed extra cells. Of 28 people, 9 died during a median follow-up of 9.5 months.
What it means for patients
Death and poor sight were linked to tumors not responding to cancer care. Stronger immune treatment, like immunoglobulin or plasmapheresis, was not linked to better results. The authors say more study of how immune cells harm the nerve is needed. They hope this work could lead to targeted drugs that help sight.
Why it is not certain yet
This review had only 32 people. The cases came from case reports and small case series. The abstract gives death figures for only 28 of the 32 people. Follow-up had a median of 9.5 months. A review can only be as good as the studies in it.
Source
Clinical features, imaging findings, and treatment outcomes of optic neuritis associated with anti-CRMP5 antibodies: a systematic review.
PubMed · PMID 42372569We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Optic neuritis publications